Podocyte depletion in Thin GBM and Alport Syndrome

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Wickman, Larysa ^a   Hodgin, Jeffrey B ^b   Wang, Su Q ^b   Afshinnia, Farsad ^b   Kershaw, David ^a   Wiggins, Roger C ^b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALPORT SYNDROME; ARTICLE; BOWMAN CAPSULE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DEPLETION; END STAGE RENAL DISEASE; ESTIMATED GLOMERULAR FILTRATION RATE; FEMALE; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BIOPSY; MALE; PODOCYTE; PROTEINURIA; CASE CONTROL STUDY; NEPHRITIS; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; GLOMERULAR BASEMENT MEMBRANE; HUMANS; NEPHRITIS, HEREDITARY; PODOCYTES;

EID: 84971280568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0155255     Document Type: Article

References (43)

1. Hudson BG. The molecular basis of Goodpasture and Alport syndromes: beacons for the discovery of the collagen IV family. J Am Soc Nephrol. 2004; 15:2514-27. PMID: 15466256
2. Deltas C, Pierides A, Voskarides K. Molecular genetics of familial hematuric diseases. Nephrol Dial Transplant 2013; 28:2946-2960. doi: 10.1093/ndt/gft253 PMID: 24046192
3. Kruegel J, Rubel D, Gross O. Alport syndrome-insights from basic and clinical research. Nat Rev Nephrol 2013; 9:170-178. doi: 10.1038/nrneph.2012.259 PMID: 23165304
4. Abrahamson DR. Role of the podocyte (and glomerular endothelium) in building the GBM. Semin Nephrol. 2012; 32:342-349. doi: 10.1016/j.semnephrol.2012.06.005 PMID: 22958488
5. Haas M. Thin Glomerular basement Membrane nephropathy. Incidence in 3471 consecutive renal biopsies examined by electron kicroscopy. Arch Pathol Lab Med 2006; 130:699-706. PMID: 16683888
6. Jais JP, Knebelmann B, Giatras I, De Marchi M, Rizzoni G, Renieri A, et al. X- linked Alport syndrome: natural history and genotype-phenotype correlations in girls and women belonging to 195 families: a "European Community Alport Syndrome Concerted Action" study. J Am Soc Nephrol. 2003; 14:2603-2610. PMID: 14514738
7. Haas M. Alport syndrome and thin glomerular basement membrane nephropathy: a practical approach to diagnosis. Arch pathol Lab Med. 2009; 133:224-232. doi: 10.1043/1543-2165-133.2.224 PMID: 19195966
8. Liapis H, Gaut J. The renal biopsy in the genomic era. Pediatr Nephrol 2013; 28:1207-1219. doi: 10.1007/s00467-012-2356-9 PMID: 23179194
9. Pierides A, Voskarides K, Athanasiou Y, Ioannou K, Damianou L, Arsali M, et al. Clinico-pathological correlations in 127 patients in 11 large pedigrees, segregating one of three heterozygous mutations in the COL4A3/ COL4A4 genes associated with familial haematuria and significant late progression to proteinuria and chronic kidney disease from focal segmental glomerulosclerosis. Nephrol Dial Transplant. 2009: 24:2721-2729 doi: 10.1093/ndt/gfp158 PMID: 19357112
10. Voskarides K, Damianou L, Neocleous V, Zouvani I, Christodoulidou S, Hadjiconstantinou V, et al. COL4A3/COL4A4 mutations producing focal segmental glomerulosclerosis and renal failure in thin basement membrane nephropathy. J Am Soc Nephrol. 2007: 18:3004-3016. PMID: 17942953
11. Malone A, Phelan P, Hall G, Cetincelik U, Homstad A, Alonso A, et al. Rare hereditary COL4A3/COL4A4 variants may be mistaken for familial focal segmental glomerulosclerosis. 2014; 86:1253-9. doi: 10.1038/ki.2014.305 PMID: 25229338
12. Gast C, Pengelly R, Lyon M, Bunyan D, Seaby E, Graham N, et al. Collagen (COL4A) mutations are the most frequent mutations underlying adult focal segmental glomerulosclerosis. Nephrol Dial Transplant 2015 [e-pub ahead of print].
13. Deltas C, Savva I, Voskarides K, Papazachariou L, Pierides A. Carriers of autosomal recessive Alport Syndrome with thin GBM nephropathy presenting as focal segmental glomerulosclerosis in later life. Nephron 2015; 130:271-280 doi: 10.1159/000435789 PMID: 26201269
14. Wiggins R: The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int 2007; 71:1205-1214. PMID: 17410103
15. Kriz W, Gretz N, Lemley KV: Progression of glomerular diseases: is the podocyte the culprit? Kidney Int. 1998; 56:687-97.
16. Kriz W, LeHir M. Pathways to nephron loss starting from glomerular diseases-insights from animal models. Kidney Int. 2005; 67:404-19. PMID: 15673288
17. LeHir M, Kriz W. New insights into structural patterns encountered in glomerulosclerosis. Curr Opin Nephrol Hypertens. 2007; 16:184-91. PMID: 17420660
18. Kim YH, Goyal M, Kurnit D, Wharram B, Wiggins J, Holzman L, et al. Podocyte depletion and glomerulosclerosis have a direct relationship in the PAN-treated rat. Kidney Int 2001; 60:957-968. PMID: 11532090
19. Wharram BL, Goyal M, Gillespie PJ, Wiggins JE, Kershaw DB, Holzman LB, et al. Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol 2005; 16:2941-2952. PMID: 16107576
20. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, et al. A Single-Gene Cause in 29.5% of Cases of Steroid-Resistant Nephrotic Syndrome. J Am Soc Nephrol. 2015; 26:1279-98 doi: 10.1681/ASN.2014050489 PMID: 25349199
21. Pagtalunan ME, Miller PL, Jumping-Eagle S, Nelson RG, Myers BD, Rennke HG, et al. Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997; 99:342-348. PMID: 9006003
22. Steffes MW, Schmidt D, McCrery R, Basgen JM: International Diabetic Nephropathy Study Group: Glomerular cell number in normal subjects and type I diabetes patients. Kidney Int 2001; 59:2104-2113. PMID: 11380812
23. White KE, Bilous RW, Marshall SM, El Nahas M, Remuzzi G, Piras G, et al. European Study for the Prevention of Renal Disease in Type I diabetes (ESPRIT): Podocyte number in normotensive type I diabetic patients with albuminuria. Diabetes 2002; 51: 3083-3089. PMID: 12351451
24. Lemley KV, Lafayette RA, Safai M, Derby G, Blouch K, Squarer A, Myers BD: Podocytopenia and disease severity in IgA nephropathy. Kidney Int 2002; 61:1475-1485. PMID: 11918755
25. Dalla Vestra M, Masiero A, Roiter AM, Saller A, Crepaldi G, Fioretto P: Is podocyte injury relevant in diabetic nephropathy? Studies in patients with type 2 diabetes. Diabetes 2003; 52:1031-1035. PMID: 12663476
26. Wang G, Lai FM, Kwan BC, Lai KB, Chow KM, Li PK, Szeto CC. Podocyte loss in human hypertensive nephrosclerosis. Am J Hypertens 2009; 22:300-6. doi: 10.1038/ajh.2008.360 PMID: 19131934
27. Yang Y, Hodgin J, Afshinnia F, Wang S, Wickman L, Chowdhury M, et al. The two kidney to one kidney transition and transplant glomerulopathy: A podocyte perspective. J Am Soc Nephrol 2014; 26;1450-65 doi: 10.1681/ASN.2014030287 PMID: 25388223
28. Sato Y, Wharram BL, Lee SK, Wickman L, Goyal M, Venkatareddy M, et al. Urine podocyte mRNAs mark progression of renal disease. J Am Soc Nephrol 2009; 20:1041-1052. doi: 10.1681/ASN.2007121328 PMID: 19389856
29. Fukuda A, Wickman LT, Venkatareddy MP, Sato Y, Chowdhury MA, Wang SQ, et al. Angiotensin II-dependent persistent podocyte loss from destabilized glomeruli causes progression of end stage kidney disease. Kidney Int 2012; 81:40-55. doi: 10.1038/ki.2011.306 PMID: 21937979
30. Fukuda A, Chowdhury M, Venkatareddy M, Wang SQ, Nishizono R, Wickman L, et al. Growth-dependent podocyte failure causes glomerulosclerosis. J Am Soc Nephrol. 2012; 23:1351-63. doi: 10.1681/ASN.2012030271 PMID: 22773827
31. Wickman L, Afshinnia F, Yang Y, Wang SQ, Wang F, Chowdhury M, et al. Urine podocyte mRNAs, proteinuria and progression in human glomerular diseases. J Am Soc Nephrol. 2013; 24:2081-95 doi: 10.1681/ASN.2013020173 PMID: 24052633
32. Hodgin J, Bitzer M, Wickman L, Afshinnia F, Wang S, Yang Y, et al. Kidney aging and Focal Global Glomerulosclerosis. A podometric perspective. J Am Soc Nephrol. 2015: 26:3162-78 doi: 10.1681/ASN.2014080752 PMID: 26038526
33. Venkatareddy M, Wang SQ, Yang Y, Patel S, Wickman L, Nishizono R, et al. Estimating podocyte number and density in histologic sections. J Am Soc Nephrol. 2014; 25:1118-1129. doi: 10.1681/ASN.2013080859 PMID: 24357669
34. Weibel ER, Gomez DM: A principle for counting tissue structures on random sections. J Appl Physiol 17: 343-348,1962 PMID: 14005589
35. Weibel ER: Elementary introduction to stereological principles. In: Stereologic Methods: Practical Methods for Biologic Morphometry, London, Academic Press Inc, 1979, pp 40-116, 415
36. Tsai WC, Wu HY, Peng YS, Ko MJ, Wu MS, Hung KY, et al. Risk Factors for Development and Progression of Chronic Kidney Disease: A Systematic Review and Exploratory Meta-Analysis. Medicine (Baltimore). 2016: 95:e3013.
37. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int. 1996: 49:1774-7. PMID: 8743495
38. Savige J. Alport syndrome: its effects on the glomerular filtration barrier and implications for future treatment. J Physiol. 2014: 592:4013-4023. doi: 10.1113/jphysiol.2014.274449 PMID: 25107927
39. Duffield JS. Cellular and molecular mechanisms in kidney fibrosis. J Clin Invest. 2014: 124:2299-2306 doi: 10.1172/JCI72267 PMID: 24892703
40. Gross O, Licht C, Anders H, Hoppe B, Tonshoff B, Hocker B, et al. Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int. 2012; 8:494-501.
41. Savige J, Gregory M, Gross O, Kashtan C, Ding J, Flinter F. Expert guidelines for the management of Alport Syndrome and Thin Basement Membrane Nephropathy. J Am Soc Nephrol 2013; 24:364-375. doi: 10.1681/ASN.2012020148 PMID: 23349312
42. Kashtan C, Ding J, Gregory M, Gross O, Heidet L, Knebelmann B, et al. Clinical practice recommendations for the treatment of Alport syndrome: a statement of the Alport syndrome research Collaborative. Pediatr Nephrol 2005; 28:5-11.
43. Wenmann DO, Hsu HH, Pavenstädt H. The renin-angiotensin-aldosterone system in podocytes. Semin Nephrol. 2012; 32:377-84. doi: 10.1016/j.semnephrol.2012.06.009 PMID: 22958492